Pamela Ann Connealy - CFO & COO at Pyxis Oncology, Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Pamela Ann Connealy since 28 Sep 2025

Reported holdings for Pamela Ann Connealy in Pyxis Oncology, Inc.

Form 4 holding CFO & COO

Pyxis Oncology, Inc.

Security class
Common Stock
Shares / value
1,199,143
Estimated value
$2,350,320
Report date
26 Nov 2024
Price
$1.96
Ownership
By Spouse
Form 4 holding CFO & COO

Pyxis Oncology, Inc.

Security class
Common Stock
Shares / value
1,115,743
Estimated value
$2,231,486
Report date
26 Nov 2024
Price
$2.00
Ownership
By Trust
Form 4 holding CFO & COO

Pyxis Oncology, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
414,163
Estimated value
$405,880
Report date
31 Mar 2025
Price
$0.9800
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Pamela Ann Connealy in Pyxis Oncology, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .